Long-term visual outcomes for a treat-&-extend anti-vascular endothelial growth factor regimen in eyes with neovascular age-related macular degeneration: Up to eight-year follow-up

被引:0
|
作者
Javidi, Simon [1 ]
Dirani, Ali [1 ,2 ]
Antaki, Fares [1 ]
Saab, Marc [1 ]
Cordahi, Ghassan [1 ]
机构
[1] Univ Montreal, Ophthalmol, Montreal, PQ, Canada
[2] Univ Laval, Ophthalmol, Quebec City, PQ, Canada
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1200
引用
收藏
页数:2
相关论文
共 50 条
  • [21] LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
    Muftuoglu, Ilkay Kilic
    Alam, Mostafa
    You, Qi Sheng
    Gaber, Raouf
    Ramkumar, Hema L.
    Mendoza, Nadia
    Meshi, Amit
    Freeman, William R.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (03): : 516 - 522
  • [22] Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: Outcomes in eyes with poor initial vision
    Toth, Levente A.
    Chakravarthy, Usha
    Stevenson, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [23] Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections
    Obeid, Anthony
    Gao, Xinxiao
    Ali, Ferhina S.
    Aderman, Christopher M.
    Shahlaee, Abtin
    Adam, Murtaza K.
    Kasi, Sundeep K.
    Hyman, Leslie
    Ho, Allen C.
    Hsu, Jason
    JAMA OPHTHALMOLOGY, 2018, 136 (11) : 1251 - 1259
  • [24] Impact of Sub-Retinal Fluid on the Long-Term Incidence of Macular Atrophy in Neovascular Age-related Macular Degeneration under Treat & Extend Anti-Vascular Endothelial Growth Factor Inhibitors
    Siedlecki, Jakob
    Fischer, Cheryl
    Schworm, Benedikt
    Kreutzer, Thomas C.
    Luft, Nikolaus
    Kortuem, Karsten U.
    Schumann, Ricarda G.
    Wolf, Armin
    Priglinger, Siegfried G.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [25] Impact of Sub-Retinal Fluid on the Long-Term Incidence of Macular Atrophy in Neovascular Age-related Macular Degeneration under Treat & Extend Anti-Vascular Endothelial Growth Factor Inhibitors
    Jakob Siedlecki
    Cheryl Fischer
    Benedikt Schworm
    Thomas C. Kreutzer
    Nikolaus Luft
    Karsten U. Kortuem
    Ricarda G. Schumann
    Armin Wolf
    Siegfried G. Priglinger
    Scientific Reports, 10
  • [26] Progression of geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration (AMD): five year follow up
    Cvetkova, Nadezhda
    Maerker, David
    Helbig, Horst
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [27] PREDICTORS OF ONE-YEAR VISUAL OUTCOMES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kodjikian, Laurent
    Decullier, Evelyne
    Souied, Eric H.
    Roux, Adeline
    Aulagner, Gilles
    Huot, Laure
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (08): : 1492 - 1499
  • [28] Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents
    Chu Luan Nguyen
    Gillies, Mark C.
    Vuong Nguyen
    Daien, Vincent
    Cohn, Amy
    Banerjee, Gayatri
    Arnold, Jennifer
    OPHTHALMOLOGY, 2019, 126 (05) : 735 - 742
  • [29] Radiotherapy for anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration
    Ying, Gui-shuang
    Vanderbeek, Brian L.
    LANCET, 2024, 404 (10447): : 4 - 5
  • [30] Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration (Review)
    Sunaga, Tomiko
    Maeda, Masayuki
    Saulle, Rosella
    Ng, Sueko M.
    Sato, Miki Takenaka
    Hasegawa, Takeshi
    Mason, Andrew N.
    Noma, Hisashi
    Ota, Erika
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (06):